Literature DB >> 10715533

Signaling mechanisms of cytokine receptors and their perturbances in disease.

I P Touw1, J P De Koning, A C Ward, M H Hermans.   

Abstract

Cytokines regulate the proliferation and differentiation of cells through their interaction with specific receptors on the surface of target cells which are coupled to intracellular signal transduction pathways. The cytokine receptor class I superfamily, characterized by structural homology in the extracellular domain, includes receptors for many interleukins and hematopoietic growth factors, but also those of growth hormone, leptin, ciliary neurotrophic factor (CNTF), oncostatin M (OSM), leukemia inhibitory factor (LIF) and cardiotrophin-1 (CT-1). The receptors for interferons are structurally distinct and have therefore been categorized separately (class II cytokine receptors). The discovery of the JAK/STAT pathway in the early 1990s has been an important step forward in deciphering cytokine mediated signaling. This pathway connects activation of the receptor complexes directly to transcription of genes. Studies of humans and mice, deficient for one of the JAKs or STATs, have revealed crucial roles of these molecules in embryonic development, blood cell formation and immune responses. In addition, recent studies have revealed some of the mechanisms that control the activation of the JAKs and STATs, which contribute to signal intensity and specificity. In this review we will summarize these recent insights and discuss their implications for a variety of pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10715533     DOI: 10.1016/s0303-7207(99)00206-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

Review 1.  Suppressors of cytokine signaling in health and disease.

Authors:  Jane C Tan; Ralph Rabkin
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

Review 2.  Immunopathogenesis of vasculitis.

Authors:  Raquel Cuchacovich
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

3.  Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia.

Authors:  F Schaefer; Y Chen; T Tsao; P Nouri; R Rabkin
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells.

Authors:  Hui Jin; Nathan J Lanning; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2008-05-22

5.  Protected amine labels: a versatile molecular scaffold for multiplexed nominal mass and sub-Da isotopologue quantitative proteomic reagents.

Authors:  Scott B Ficarro; Jessica M Biagi; Jinhua Wang; Jenna Scotcher; Rositsa I Koleva; Joseph D Card; Guillaume Adelmant; Huan He; Manor Askenazi; Alan G Marshall; Nicolas L Young; Nathanael S Gray; Jarrod A Marto
Journal:  J Am Soc Mass Spectrom       Date:  2014-02-05       Impact factor: 3.109

Review 6.  Perturbed signal transduction in neurodegenerative disorders involving aberrant protein aggregation.

Authors:  Mark P Mattson; Michael Sherman
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

7.  Late gestation modulation of fetal glucocorticoid effects requires the receptor for leukemia inhibitory factor: an observational study.

Authors:  Carol B Ware; Angelique M Nelson; Denny Liggitt
Journal:  Reprod Biol Endocrinol       Date:  2003-05-16       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.